Emerging Treatment Approaches and Multidisciplinary Management of Unresectable Stage III Non-Small Cell Lung Cancer

EP. 11: Key Takeaways From the PACIFIC-2 Trial: The Role of Concurrent Immunotherapy With CRT

March 6th 2025

The discussion explores promising future directions for managing locally advanced disease, focusing on combination immunotherapy approaches and the ongoing trials investigating their efficacy, as well as the potential role of combining chemotherapy (CRT) with immunotherapy in treatment regimens.

EP. 12: Closing Thoughts and Clinical Pearls: Future Perspectives in NSCLC

March 6th 2025

The expert discussion concludes with reflections on the rapid advancements in the treatment of locally advanced lung cancer, emphasizing the importance of personalized therapy, multidisciplinary collaboration, and continued progress in improving patient outcomes.